100 related articles for article (PubMed ID: 16678123)
1. ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion.
Moss AC; Lawlor G; Murray D; Tighe D; Madden SF; Mulligan AM; Keane CO; Brady HR; Doran PP; MacMathuna P
Biochem Biophys Res Commun; 2006 Jun; 345(1):216-21. PubMed ID: 16678123
[TBL] [Abstract][Full Text] [Related]
2. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J
Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133
[TBL] [Abstract][Full Text] [Related]
3. Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma.
Takita J; Chen Y; Okubo J; Sanada M; Adachi M; Ohki K; Nishimura R; Hanada R; Igarashi T; Hayashi Y; Ogawa S
Cancer Sci; 2011 Sep; 102(9):1645-50. PubMed ID: 21624008
[TBL] [Abstract][Full Text] [Related]
4. MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2.
Lawlor G; Doran PP; MacMathuna P; Murray DW
J Exp Clin Cancer Res; 2010 Jun; 29(1):81. PubMed ID: 20569498
[TBL] [Abstract][Full Text] [Related]
5. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.
Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B
Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM
Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160
[TBL] [Abstract][Full Text] [Related]
8. ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.
Tyagi N; Deshmukh SK; Srivastava SK; Azim S; Ahmad A; Al-Ghadhban A; Singh AP; Carter JE; Wang B; Singh S
Mol Cancer Res; 2018 Feb; 16(2):187-196. PubMed ID: 29117940
[TBL] [Abstract][Full Text] [Related]
9. Net1 and Myeov: computationally identified mediators of gastric cancer.
Leyden J; Murray D; Moss A; Arumuguma M; Doyle E; McEntee G; O'Keane C; Doran P; MacMathuna P
Br J Cancer; 2006 Apr; 94(8):1204-12. PubMed ID: 16552434
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
11. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
12. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells.
Hong JS; Pai HK; Hong KO; Kim MA; Kim JH; Lee JI; Hong SP; Hong SD
J Oral Pathol Med; 2009 Feb; 38(2):214-9. PubMed ID: 18624931
[TBL] [Abstract][Full Text] [Related]
13. ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis.
Dumortier M; Ladam F; Damour I; Vacher S; Bièche I; Marchand N; de Launoit Y; Tulasne D; Chotteau-Lelièvre A
Breast Cancer Res; 2018 Jul; 20(1):73. PubMed ID: 29996935
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
15. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.
Koslowski M; Sahin U; Dhaene K; Huber C; Türeci O
Cancer Res; 2008 May; 68(9):3458-66. PubMed ID: 18451174
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
[TBL] [Abstract][Full Text] [Related]
17. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
Chang YW; Marlin JW; Chance TW; Jakobi R
Cancer Res; 2006 Dec; 66(24):11700-8. PubMed ID: 17178865
[TBL] [Abstract][Full Text] [Related]
18. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
19. [Effects of allicin on invasion and metastasis of colon cancer LoVo cell line in vitro].
Gao Y; Liu YQ; Cao WK; Chen XF; Wan YY; Heng C; Xu LJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1382-6. PubMed ID: 19671326
[TBL] [Abstract][Full Text] [Related]
20. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells.
Ding W; Wang J; Sun B; Ju S; Yuan H; Wang X; Wang Y; Wang H
Clin Biochem; 2009 Nov; 42(16-17):1694-8. PubMed ID: 19573525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
